Clinical Trial Update: Treatment of Steroid Refractory Gastro-intestinal Acute GVHD afteR AllogeneiC HSCT With fEcal Microbiota tranSfer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating fecal microbiota transplantation for treatment of steroid-refractory gastrointestinal acute graft-versus-host disease after al…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Gvhd
• Graft-versus-host Disease

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: MaaT Pharma | Conditions: Fecal Microbiota Transplantation | Phase 2 | Status: COMPLETED